search
Back to results

Telehealth Referral to Improve Outcomes (TRIO)

Primary Purpose

Hypertension

Status
Suspended
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
blood pressure cuff PLUS tablet
Telehealth Consult
Sponsored by
Icahn School of Medicine at Mount Sinai
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypertension focused on measuring Asymptomatic hypertension, Referral, Telehealth, Remote patient monitoring, Emergency Department, blood pressure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥ 18 years
  • At least two* high blood pressure readings during ED visit

    1. Systolic (top #) ≥140, ≤180 AND/OR
    2. Diastolic (bottom #) ≥ 90, ≤120

      *Second blood pressure may be confirmed when approaching the patient. Before approaching, check exclusions first.

      Exclusion Criteria:

  • symptomatic hypertension

Sites / Locations

  • Mount Sinai Hospital Center Emergency Dept

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Placebo Comparator

Arm Label

TRIO PLUS tablet and nurse at day 3

TRIO PLUS Tablet and nurse at day 3 and 7

TRIO PLUS Group

Arm Description

Virtual nurse encounter at 3 days

Virtual nurse encounter at 3 days and 7 days

No encounter

Outcomes

Primary Outcome Measures

Recruitment rate
recruitment rate of patients enrolled in TRIO at 6-months.
Recruitment rate
recruitment rate of patients enrolled in TRIO at 12-months.
Retention rate
retention rate of patients enrolled in TRIO at 6-months.
Retention rate
retention rate of patients enrolled in TRIO at 12-months.
Attrition rate
attrition rate of patients enrolled in TRIO at 6-months.
Attrition rate
attrition rate of patients enrolled in TRIO at 12-months.

Secondary Outcome Measures

Blood pressure
Blood pressure
Number of participant who had follow up care
Primary Care Engagement to be defined as having follow up care (yes/no) at 6 months
Number of participant who had follow up care
Primary Care Engagement to be defined as having follow up care (yes/no) at 12 months

Full Information

First Posted
April 28, 2021
Last Updated
April 27, 2023
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
AT&T and Vital Tech
search

1. Study Identification

Unique Protocol Identification Number
NCT05000970
Brief Title
Telehealth Referral to Improve Outcomes
Acronym
TRIO
Official Title
Telehealth Referral to Improve Outcomes for Asymptomatic Hypertension in the Emergency Department
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Suspended
Why Stopped
funding
Study Start Date
July 12, 2021 (Actual)
Primary Completion Date
January 2024 (Anticipated)
Study Completion Date
April 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
AT&T and Vital Tech

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
Emergency patients often have uncontrolled asymptomatic hypertension upon discharge from the emergency department. This 3-arm randomized controlled trial will evaluate the impact of nurse telehealth encounters and remote patient monitoring, using a software called Vital Tech, on blood pressure control and primary care engagement.
Detailed Description
Emergency Department (ED) clinicians encounter patients with asymptomatic hypertension (HTN) on a daily basis but usually fail to intervene. This pilot study will determine the utility of a novel intervention: Telehealth Referral to Improve Outcomes (TRIO), a conceptually driven information technology tool focused on patients who are asymptomatic and hypertensive upon ED discharge. It is designed to successfully link them to a primary care provider (PCP) after ED discharge to improve blood pressure (BP) control. 48 adult ED patients who have asymptomatic HTN (BP >/= 140/90 mmg and </= 180/120 mmHg) and who will be discharged will be enrolled in the study. This study is a single-site, 3-arm randomized controlled pilot trial. All patients will receive a wireless BP monitor and tablet. Group 2 (N=16) will additionally receive a telehealth consult with an RN at day 3. Group 3 (N=16) will additionally receive a telehealth consult with an RN at day 3 and day 7. The research team will collect feasibility outcomes: (recruitment rate, retention rate, and attrition rate of patients enrolled in TRIO at 6-months and 12-months. The research team will evaluate BP control and engagement with primary care at 6-months and 12-months and compare between groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Asymptomatic hypertension, Referral, Telehealth, Remote patient monitoring, Emergency Department, blood pressure

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
ParticipantInvestigator
Masking Description
Both participant and investigator will be blinded on the study assignment group.
Allocation
Randomized
Enrollment
48 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
TRIO PLUS tablet and nurse at day 3
Arm Type
Experimental
Arm Description
Virtual nurse encounter at 3 days
Arm Title
TRIO PLUS Tablet and nurse at day 3 and 7
Arm Type
Experimental
Arm Description
Virtual nurse encounter at 3 days and 7 days
Arm Title
TRIO PLUS Group
Arm Type
Placebo Comparator
Arm Description
No encounter
Intervention Type
Device
Intervention Name(s)
blood pressure cuff PLUS tablet
Other Intervention Name(s)
wireless BP monitor and tablet
Intervention Description
all arms
Intervention Type
Other
Intervention Name(s)
Telehealth Consult
Intervention Description
Telehealth consult with an RN
Primary Outcome Measure Information:
Title
Recruitment rate
Description
recruitment rate of patients enrolled in TRIO at 6-months.
Time Frame
6 months
Title
Recruitment rate
Description
recruitment rate of patients enrolled in TRIO at 12-months.
Time Frame
12 months
Title
Retention rate
Description
retention rate of patients enrolled in TRIO at 6-months.
Time Frame
6 months
Title
Retention rate
Description
retention rate of patients enrolled in TRIO at 12-months.
Time Frame
12 months
Title
Attrition rate
Description
attrition rate of patients enrolled in TRIO at 6-months.
Time Frame
6 months
Title
Attrition rate
Description
attrition rate of patients enrolled in TRIO at 12-months.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Blood pressure
Time Frame
6 months
Title
Blood pressure
Time Frame
12 months
Title
Number of participant who had follow up care
Description
Primary Care Engagement to be defined as having follow up care (yes/no) at 6 months
Time Frame
6 months
Title
Number of participant who had follow up care
Description
Primary Care Engagement to be defined as having follow up care (yes/no) at 12 months
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years At least two* high blood pressure readings during ED visit Systolic (top #) ≥140, ≤180 AND/OR Diastolic (bottom #) ≥ 90, ≤120 *Second blood pressure may be confirmed when approaching the patient. Before approaching, check exclusions first. Exclusion Criteria: symptomatic hypertension
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kimberly Souffront, PhD, APRN
Organizational Affiliation
Icahn School of Medicine at Mount Sinai
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mount Sinai Hospital Center Emergency Dept
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Telehealth Referral to Improve Outcomes

We'll reach out to this number within 24 hrs